| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | POU domain binding | 5.53e-05 | 7 | 33 | 2 | GO:0070974 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 2.04e-04 | 13 | 33 | 2 | GO:0001162 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 3.55e-04 | 17 | 33 | 2 | GO:0001161 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 6.56e-04 | 23 | 33 | 2 | GO:0071837 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.12e-03 | 30 | 33 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.20e-03 | 31 | 33 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.85e-03 | 48 | 33 | 2 | GO:0016620 | |
| GeneOntologyMolecularFunction | miRNA binding | 2.85e-03 | 48 | 33 | 2 | GO:0035198 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 3.86e-03 | 56 | 33 | 2 | GO:0016903 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.27e-03 | 59 | 33 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.27e-03 | 59 | 33 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 4.71e-03 | 62 | 33 | 2 | GO:0061980 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.15e-03 | 227 | 33 | 3 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | 7.71e-03 | 479 | 33 | 4 | GO:0003779 | |
| GeneOntologyBiologicalProcess | trophectodermal cell fate commitment | 6.99e-06 | 3 | 32 | 2 | GO:0001830 | |
| GeneOntologyBiologicalProcess | ectodermal cell fate commitment | 2.33e-05 | 5 | 32 | 2 | GO:0001712 | |
| GeneOntologyBiologicalProcess | ectoderm formation | 4.87e-05 | 7 | 32 | 2 | GO:0001705 | |
| GeneOntologyBiologicalProcess | ectodermal cell differentiation | 8.34e-05 | 9 | 32 | 2 | GO:0010668 | |
| GeneOntologyBiologicalProcess | germ-line stem cell population maintenance | 1.04e-04 | 10 | 32 | 2 | GO:0030718 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 1.27e-04 | 11 | 32 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion-dependent exocytosis | 1.27e-04 | 11 | 32 | 2 | GO:0045955 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 2.83e-04 | 382 | 32 | 5 | GO:0016042 | |
| GeneOntologyBiologicalProcess | lipid modification | 3.23e-04 | 214 | 32 | 4 | GO:0030258 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 3.51e-04 | 18 | 32 | 2 | GO:0001711 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 3.35e-04 | 86 | 33 | 3 | GO:0001673 | |
| GeneOntologyCellularComponent | germ cell nucleus | 7.46e-04 | 113 | 33 | 3 | GO:0043073 | |
| GeneOntologyCellularComponent | female germ cell nucleus | 1.09e-03 | 31 | 33 | 2 | GO:0001674 | |
| GeneOntologyCellularComponent | mitochondrial matrix | 1.28e-03 | 523 | 33 | 5 | GO:0005759 | |
| Domain | POU_dom_5 | 9.64e-06 | 3 | 34 | 2 | IPR015585 | |
| Domain | POU | 3.80e-04 | 16 | 34 | 2 | SM00352 | |
| Domain | POU_2 | 3.80e-04 | 16 | 34 | 2 | PS00465 | |
| Domain | Pou | 3.80e-04 | 16 | 34 | 2 | PF00157 | |
| Domain | POU_dom | 3.80e-04 | 16 | 34 | 2 | IPR000327 | |
| Domain | POU_3 | 3.80e-04 | 16 | 34 | 2 | PS51179 | |
| Domain | POU_1 | 3.80e-04 | 16 | 34 | 2 | PS00035 | |
| Domain | POU | 4.30e-04 | 17 | 34 | 2 | IPR013847 | |
| Domain | - | 1.10e-03 | 27 | 34 | 2 | 1.10.260.40 | |
| Domain | - | 1.10e-03 | 27 | 34 | 2 | 2.130.10.80 | |
| Domain | Aden_trnslctor | 1.18e-03 | 28 | 34 | 2 | IPR002113 | |
| Domain | Lambda_DNA-bd_dom | 1.27e-03 | 29 | 34 | 2 | IPR010982 | |
| Domain | Gal_Oxidase_b-propeller | 1.74e-03 | 34 | 34 | 2 | IPR015916 | |
| Domain | BTB-kelch_protein | 2.77e-03 | 43 | 34 | 2 | IPR017096 | |
| Domain | SOLCAR | 4.18e-03 | 53 | 34 | 2 | PS50920 | |
| Domain | Mito_carr | 4.18e-03 | 53 | 34 | 2 | PF00153 | |
| Domain | - | 4.18e-03 | 53 | 34 | 2 | 1.50.40.10 | |
| Domain | Mt_carrier_dom | 4.18e-03 | 53 | 34 | 2 | IPR023395 | |
| Domain | Mitochondrial_sb/sol_carrier | 4.18e-03 | 53 | 34 | 2 | IPR018108 | |
| Domain | Kelch | 4.99e-03 | 58 | 34 | 2 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 5.16e-03 | 59 | 34 | 2 | IPR011043 | |
| Domain | BACK | 5.33e-03 | 60 | 34 | 2 | SM00875 | |
| Domain | BACK | 5.50e-03 | 61 | 34 | 2 | PF07707 | |
| Domain | BACK | 5.50e-03 | 61 | 34 | 2 | IPR011705 | |
| Domain | Kelch_1 | 7.19e-03 | 70 | 34 | 2 | PF01344 | |
| Domain | Kelch_1 | 7.19e-03 | 70 | 34 | 2 | IPR006652 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 5.40e-05 | 42 | 25 | 3 | M699 | |
| Pathway | WP_MIRNAS_AND_TFS_IN_IPS_CELL_GENERATION | 8.40e-05 | 8 | 25 | 2 | MM15855 | |
| Pathway | WP_KETOGENESIS_AND_KETOLYSIS | 8.40e-05 | 8 | 25 | 2 | M39836 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31843009 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29266259 | ||
| Pubmed | The Effect of Melatonin on OCT4 Expression and Granulosa Cell Growth in Female Mice. | 9.28e-07 | 2 | 34 | 2 | 34735714 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12110668 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31277213 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35501657 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15685634 | ||
| Pubmed | Nucleosome Clutches are Regulated by Chromatin Internal Parameters. | 9.28e-07 | 2 | 34 | 2 | 33181171 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26832419 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 37895112 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16950240 | ||
| Pubmed | Maternal Oct-4 is a potential key regulator of the developmental competence of mouse oocytes. | 9.28e-07 | 2 | 34 | 2 | 18837968 | |
| Pubmed | The homeodomain of Oct4 is a dimeric binder of methylated CpG elements. | 9.28e-07 | 2 | 34 | 2 | 36631980 | |
| Pubmed | [Investigation of transcriptional regulation of Oct4 (POU5F1) gene with distal enhancer]. | 9.28e-07 | 2 | 34 | 2 | 25509123 | |
| Pubmed | Cruciform Formable Sequences within Pou5f1 Enhancer Are Indispensable for Mouse ES Cell Integrity. | 9.28e-07 | 2 | 34 | 2 | 33810223 | |
| Pubmed | Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. | 9.28e-07 | 2 | 34 | 2 | 18063756 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22120493 | ||
| Pubmed | Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions. | 9.28e-07 | 2 | 34 | 2 | 26435056 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19664601 | ||
| Pubmed | Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency. | 9.28e-07 | 2 | 34 | 2 | 28157483 | |
| Pubmed | Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. | 9.28e-07 | 2 | 34 | 2 | 9507072 | |
| Pubmed | Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines. | 9.28e-07 | 2 | 34 | 2 | 19784378 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28988986 | ||
| Pubmed | Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos. | 9.28e-07 | 2 | 34 | 2 | 18932201 | |
| Pubmed | Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo. | 9.28e-07 | 2 | 34 | 2 | 15548425 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 25043178 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 36130732 | ||
| Pubmed | A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. | 9.28e-07 | 2 | 34 | 2 | 1972777 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 1915274 | ||
| Pubmed | Mouse Oct-3 maps between the tcl12 embryonic lethal gene and the Qa gene in the H-2 complex. | 9.28e-07 | 2 | 34 | 2 | 1680810 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31222057 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20376339 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30653498 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9835353 | ||
| Pubmed | Effect of ploidy and parental genome composition on expression of Oct-4 protein in mouse embryos. | 9.28e-07 | 2 | 34 | 2 | 15183310 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30209362 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15996113 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34788058 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21083502 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24104477 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26804242 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21502535 | ||
| Pubmed | Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. | 9.28e-07 | 2 | 34 | 2 | 17525163 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 14990861 | ||
| Pubmed | OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation. | 9.28e-07 | 2 | 34 | 2 | 27499297 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16772384 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11839818 | ||
| Pubmed | Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. | 9.28e-07 | 2 | 34 | 2 | 24561253 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34948221 | ||
| Pubmed | Auxin-degron system identifies immediate mechanisms of OCT4. | 9.28e-07 | 2 | 34 | 2 | 34143975 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 27302093 | ||
| Pubmed | Characterization of a negative retinoic acid response element in the murine Oct4 promoter. | 9.28e-07 | 2 | 34 | 2 | 8289793 | |
| Pubmed | Force via integrins but not E-cadherin decreases Oct3/4 expression in embryonic stem cells. | 9.28e-07 | 2 | 34 | 2 | 22037576 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31624145 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22704655 | ||
| Pubmed | Oct4 redox sensitivity potentiates reprogramming and differentiation. | 9.28e-07 | 2 | 34 | 2 | 38719541 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 33221301 | ||
| Pubmed | Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. | 9.28e-07 | 2 | 34 | 2 | 11309664 | |
| Pubmed | Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro. | 9.28e-07 | 2 | 34 | 2 | 12641567 | |
| Pubmed | Post-translational regulation of Oct4 transcriptional activity. | 9.28e-07 | 2 | 34 | 2 | 19221599 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21285944 | ||
| Pubmed | A nontranscriptional role for Oct4 in the regulation of mitotic entry. | 9.28e-07 | 2 | 34 | 2 | 25324523 | |
| Pubmed | A novel subpopulation lacking Oct4 expression in the testicular side population. | 9.28e-07 | 2 | 34 | 2 | 16328007 | |
| Pubmed | A unique Oct4 interface is crucial for reprogramming to pluripotency. | 9.28e-07 | 2 | 34 | 2 | 23376973 | |
| Pubmed | Oct4 kinetics predict cell lineage patterning in the early mammalian embryo. | 9.28e-07 | 2 | 34 | 2 | 21258368 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23580657 | ||
| Pubmed | Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. | 9.28e-07 | 2 | 34 | 2 | 17724450 | |
| Pubmed | Novel variants of Oct-3/4 gene expressed in mouse somatic cells. | 9.28e-07 | 2 | 34 | 2 | 18765667 | |
| Pubmed | Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. | 9.28e-07 | 2 | 34 | 2 | 18283123 | |
| Pubmed | Transcriptional activation by Oct4 is sufficient for the maintenance and induction of pluripotency. | 9.28e-07 | 2 | 34 | 2 | 22832160 | |
| Pubmed | Gonadotropins affect Oct-4 gene expression during mouse oocyte growth. | 9.28e-07 | 2 | 34 | 2 | 16496425 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16932739 | ||
| Pubmed | A conserved Oct4/POUV-dependent network links adhesion and migration to progenitor maintenance. | 9.28e-07 | 2 | 34 | 2 | 24210613 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15955835 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34463738 | ||
| Pubmed | Differential expression of Oct3/4 in human breast cancer and normal tissues. | 9.28e-07 | 2 | 34 | 2 | 29620155 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20412747 | ||
| Pubmed | Oct4 promoter activity in stem cells obtained through somatic reprogramming. | 9.28e-07 | 2 | 34 | 2 | 23550731 | |
| Pubmed | Glutamine Metabolism Regulates the Pluripotency Transcription Factor OCT4. | 9.28e-07 | 2 | 34 | 2 | 27346346 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30762028 | ||
| Pubmed | POU-V factors antagonize maternal VegT activity and beta-Catenin signaling in Xenopus embryos. | 9.28e-07 | 2 | 34 | 2 | 17541407 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26615201 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17932422 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22730289 | ||
| Pubmed | Secondary structure of the oct-3 POU homeodomain as determined by 1H-15N NMR spectroscopy. | 9.28e-07 | 2 | 34 | 2 | 8097478 | |
| Pubmed | Identification of a homologue of POU5F1 (OCT3/4) in a marsupial, the brushtail possum. | 9.28e-07 | 2 | 34 | 2 | 11170265 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 32930837 | ||
| Pubmed | Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. | 9.28e-07 | 2 | 34 | 2 | 17183653 | |
| Pubmed | A novel variant of Oct3/4 gene in mouse embryonic stem cells. | 9.28e-07 | 2 | 34 | 2 | 22683460 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23963638 | ||
| Pubmed | In silico tandem affinity purification refines an Oct4 interaction list. | 9.28e-07 | 2 | 34 | 2 | 21569470 | |
| Pubmed | Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming. | 9.28e-07 | 2 | 34 | 2 | 26877091 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12615074 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19641521 | ||
| Pubmed | OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells. | 9.28e-07 | 2 | 34 | 2 | 29216265 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22367590 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20439621 | ||
| Pubmed | Loss of Oct4 expression during the development of murine embryoid bodies. | 9.28e-07 | 2 | 34 | 2 | 22960235 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20219939 | ||
| Pubmed | Oct4 distribution and level in mouse clones: consequences for pluripotency. | 9.28e-07 | 2 | 34 | 2 | 12023300 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 3.20e-04 | 23 | 21 | 2 | 523 | |
| GeneFamily | Solute carriers | 1.00e-03 | 395 | 21 | 4 | 752 | |
| GeneFamily | Kelch like|BTB domain containing | 1.08e-03 | 42 | 21 | 2 | 617 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.04e-02 | 134 | 21 | 2 | 861 | |
| Coexpression | MOOTHA_HUMAN_MITODB_6_2002 | 1.76e-05 | 432 | 34 | 6 | M9433 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 | 5.85e-05 | 9 | 34 | 2 | MM608 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 7.30e-05 | 10 | 34 | 2 | MM741 | |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_UP | 1.20e-04 | 197 | 34 | 4 | M3348 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN | 1.25e-04 | 199 | 34 | 4 | M4200 | |
| Coexpression | GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP | 1.28e-04 | 200 | 34 | 4 | M7742 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 1.28e-04 | 200 | 34 | 4 | M6626 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-06 | 153 | 34 | 4 | d9e2c386875bc15e1e6e75dc7acf05c0dc8c306b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.25e-06 | 164 | 34 | 4 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-06 | 172 | 34 | 4 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-06 | 172 | 34 | 4 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-06 | 172 | 34 | 4 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| Drug | n-propionyl-CoA | 4.55e-06 | 166 | 34 | 5 | CID000001033 | |
| Drug | succinyl-coenzyme A | 4.55e-06 | 166 | 34 | 5 | CID000001111 | |
| Drug | AC1L975Q | 6.03e-06 | 24 | 34 | 3 | CID000439337 | |
| Drug | AC1L2LUF | 1.30e-05 | 4 | 34 | 2 | CID000074406 | |
| Drug | AC1Q68Z5 | 2.06e-05 | 386 | 34 | 6 | CID000000181 | |
| Drug | AC1L1GAZ | 3.60e-05 | 43 | 34 | 3 | CID000003605 | |
| Drug | butyraldehyde | 5.03e-05 | 48 | 34 | 3 | CID000000261 | |
| Drug | 1-butyl-3-methylimidazolium | 6.03e-05 | 8 | 34 | 2 | CID002734161 | |
| Drug | glutaconyl-CoA | 6.03e-05 | 8 | 34 | 2 | CID009543049 | |
| Drug | AC1MI0E8 | 6.03e-05 | 8 | 34 | 2 | CID003036008 | |
| Drug | potassium persulfate | 6.03e-05 | 8 | 34 | 2 | CID000024412 | |
| Drug | CPD-226 | 7.74e-05 | 9 | 34 | 2 | CID000439705 | |
| Drug | 3-Hydroxybutanoyl-Coenzyme A | 8.42e-05 | 57 | 34 | 3 | CID000000521 | |
| Drug | zearalanone | 1.18e-04 | 11 | 34 | 2 | CID000108003 | |
| Drug | AC1L193Y | 1.25e-04 | 65 | 34 | 3 | CID000000380 | |
| Drug | beta-hydroxybutyrate | 1.42e-04 | 179 | 34 | 4 | CID000000441 | |
| Drug | reduced diphosphopyridine nucleotide | 1.44e-04 | 342 | 34 | 5 | CID000000928 | |
| Drug | octanoate | 1.49e-04 | 181 | 34 | 4 | CID000000379 | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 3208_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 4757_UP | |
| Drug | AC1Q68ZE | 2.23e-04 | 79 | 34 | 3 | CID000000265 | |
| Drug | N,N'-methylenebisacrylamide | 2.25e-04 | 15 | 34 | 2 | CID000008041 | |
| Drug | 3-ketoadipyl-CoA | 2.25e-04 | 15 | 34 | 2 | CID000000094 | |
| Drug | 3-hydroxyoctanoate | 2.25e-04 | 15 | 34 | 2 | CID000026613 | |
| Drug | CO(2 | 2.30e-04 | 378 | 34 | 5 | CID000000280 | |
| Drug | acetate | 2.32e-04 | 599 | 34 | 6 | CID000000175 | |
| Disease | L-arginine measurement | 3.69e-04 | 27 | 31 | 2 | EFO_0006524 | |
| Disease | Osteoporosis, Age-Related | 1.88e-03 | 61 | 31 | 2 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 1.88e-03 | 61 | 31 | 2 | C0751406 | |
| Disease | Osteoporosis, Senile | 1.88e-03 | 61 | 31 | 2 | C0029459 | |
| Disease | Osteoporosis | 2.00e-03 | 63 | 31 | 2 | C0029456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTAGPGACGLGAVGQ | 751 | Q5SNV9 | |
| PGSVCAVFGLGGVGL | 191 | P11766 | |
| VYVGTAPSGCIGGLG | 56 | Q13515 | |
| VGAIAGAGILYGVAP | 96 | P55064 | |
| GGMAYCGPQVGVGLV | 71 | Q06416 | |
| AVITPYGECILGAGG | 456 | Q9BV94 | |
| EAGVGLGIGLCSVPY | 361 | Q14005 | |
| AGGFGGVCLVFVGHP | 16 | O43772 | |
| YQGGVILGCLFGPAA | 346 | P49279 | |
| VCGFGGPYGETVATG | 891 | Q9NZB2 | |
| GIRGLCNGLGPALYG | 376 | Q96MC6 | |
| GGMAYCGPQVGVGLV | 71 | Q01860 | |
| RCEGAGPVLFAVGGG | 336 | Q6TDP4 | |
| GELGVLGPTIKGYGC | 101 | Q92947 | |
| LRQIYGCPLGGIGGG | 146 | Q9HCG7 | |
| SGVQCYGPGIEGQGV | 1256 | P21333 | |
| ILGLGDLGCYGMGIP | 191 | Q16798 | |
| YVVPVGGVRAGLCGQ | 326 | Q5BKX5 | |
| PGCLDGGGVQYLLVG | 36 | Q14D33 | |
| AVCIGILPGLGAYSG | 206 | Q9GZU8 | |
| GVVGCVIILNFGGGY | 36 | P03923 | |
| RGGEGPGGSTAYVVC | 176 | A6NL88 | |
| GAIGGVCGVAVGYPL | 6 | Q6Q0C1 | |
| GPGGYAVVVCIGQIV | 416 | O75083 | |
| GATVLVGGFGLCGIP | 56 | P55809 | |
| APVVGGSGGVYALCS | 306 | O75783 | |
| VPLIIAAGGGGRAYG | 836 | Q9UM73 | |
| YAVGSACIGGGQGIA | 376 | P42765 | |
| YGGNGIVGAQVPLGA | 161 | P08559 | |
| GAGPLCVLGGAALGV | 6 | Q8NEW7 | |
| KVGGPVYRIGVGGGA | 451 | O15067 | |
| AAGACYAAGGLQVPG | 151 | Q96G79 | |
| AGGQGGAAPVYPVLC | 96 | Q9UL49 | |
| CDGLGQVVGEYKGPG | 661 | Q9BRZ2 | |
| ELIPGGAGIVVGYGD | 681 | Q5T447 | |
| GVGVVGGLLYAVGGY | 441 | O95198 |